Labshake search
Citations for Stemcell Technologies :
551 - 600 of 1831 citations for Human Lactase Like Protein LCTL ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: Human peripheral blood mononuclear cells were purchased from Stemcell Technologies (#70025) and CD8+ T cells isolated using the EasySep Human CD8+ T Cell Isolation kit (Stemcell Technologies ...
-
bioRxiv - Physiology 2020Quote: ... enteroids were maintained in Human IntestiCult components A+B (STEMCELL Technologies). To promote differentiation ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies), 1 mM Dibutyryl-cAMP (PeproTech) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 ng/ml Recombinant Human Brain-Derived Neurotrophic Factor (StemCell Technologies), 20 ng/ml Recombinant Human Glial-Derived Neurotrophic Factor (StemCell Technologies) ...
-
bioRxiv - Immunology 2022Quote: ... and human BAFF46 in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 μg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Microbiology 2020Quote: ... Human bone marrow CD34+ HPCs were obtained from Stem cell Technologies and recovered in SFEMII (Stem Cell Technologies ...
-
bioRxiv - Immunology 2022Quote: CD34+ cells were isolated from human cord blood (Stemcell Technologies #17896) and cultured for 2 days in expansion media (Miltenyi #130-100-473) ...
-
bioRxiv - Molecular Biology 2021Quote: Human PBMCs were isolated from healthy peripheral whole blood (STEMCELL Technologies) by using gradient method with the Ficoll-Paque (GE Healthcare) ...
-
bioRxiv - Bioengineering 2021Quote: ... additionally supplemented with cytokines (Human Recombinant IL-2; Stemcell Technologies - #78036). To stimulate the cells ...
-
Loss of TREM2 reduces hyperactivation of progranulin deficient microglia but not lysosomal pathologybioRxiv - Neuroscience 2021Quote: ... in combination with RosetteSep Human Monocyte Enrichment Cocktail (StemCell Technologies, #15068) according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2020Quote: ... and human BAFF52 in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 μg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Immunology 2020Quote: ... and Easysep release human biotin positive selection cocktail (17653, STEMCELL Technologies). CD19+CD11c+ B cells (ABCs ...
-
bioRxiv - Genetics 2019Quote: Human iPSCs were cultured on vitronectin-XF-coated plates (Stemcell Technologies) and TeSR-E8 medium (Stemcell Technologies) ...
-
bioRxiv - Genomics 2021Quote: Human peripheral blood mononuclear cells were purchased from Stemcell Technologies (#70025) and T cells isolated using the EasySep Human T Cell Isolation kit (Stemcell Technologies ...
-
bioRxiv - Cancer Biology 2022Quote: Cryopreserved human cord blood-derived CD34+ cells (STEMCELL Technologies, Cambridge, MA) were rapidly thawed at 37°C ...
-
bioRxiv - Cancer Biology 2022Quote: ... 20 ng/ml human recombinant epidermal growth factor (STEMCELL Technologies, 78006.1), 10 ng/ml human recombinant basic fibroblast growth factor (STEMCELL Technologies ...
-
bioRxiv - Immunology 2022Quote: For monocyte/macrophage monocultures cryopreserved primary human CD14+ monocytes (Stemcell Technologies) isolated from peripheral blood were plated at 300,000 cells/well in flat bottom ...
-
NSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in micebioRxiv - Neuroscience 2022Quote: ... Human iPSCs were cultured with STEMdiff Neural Induction Medium (Stemcell Technologies). The medium was replaced daily until day 9 ...
-
bioRxiv - Molecular Biology 2023Quote: Human Peripheral Blood Mononuclear Cells (PBMCs) were purchased from StemCell Technology. Samples from three individual donors were thawed at 37°C for 3 minutes and then diluted into 5 mL of FACS buffer (0.5% BSA in 1x PBS) ...
-
bioRxiv - Neuroscience 2023Quote: ... Human iPSC cells were cultured in mTeSR Plus (Stem Cell Technology) on 5 µg/ml BioLaminin 521LN (Biolamina ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 50 ng/uL Human Recombinant M-CSF (STEMCELL Technologies) for 4 days ...
-
bioRxiv - Cancer Biology 2022Quote: ... and human EGF (20 ng/ml, Stem Cell Technologies, cat# 78006). HMC3 human microglia cell line is cultured in Eagle’s Minimum Essential Medium (EMEM ...
-
bioRxiv - Developmental Biology 2024Quote: Primed H9 human ESC were cultured according in mTeSR1 (StemCell Technologies) according to the manufacturer’s guidance ...
-
bioRxiv - Bioengineering 2023Quote: ... 0.5ug/mL human recombinant Thrombopoietin (TPO) (StemCell Technologies, Cat. No. 78210), and 1% PSG (Thermofisher ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD8+ T cells (Stem Cell Technologies, 200-0164) were cultured in ImmunoCult XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 10% NeuroCult™ Proliferation Supplement (Human) (STEMCELL Technologies, 05753), heparin solution (final concentration ...
-
bioRxiv - Bioengineering 2023Quote: Human peripheral blood CD4+ T cells (Stem Cell Technologies, 200-0165) were cultured in ImmunoCult-XF T Cell Expansion media (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2023Quote: ... human iPSCs were passaged with Accutase (Stem Cell Technologies, Vancouver, Canada) and re-plated at a density of 1 to 2×105 per cm2 in growth factor reduced Matrigel (Corning Incorporated ...
-
bioRxiv - Developmental Biology 2023Quote: ... supplemented with 10 ng/ml human FGF2 (Stem Cell Technologies 78003). Individual iPSC colonies were mechanically picked ...
-
Chimeric Antigen Cytotoxic Receptors for In-Vivo Engineering of Tumor-targeting Natural Killer CellsbioRxiv - Immunology 2023Quote: ... ImmunoCult™ human CD3/CD28/CD2 T-cell activator (StemCell Technologies) was used to activate isolated T cells in vitro for 2 days following the manufacturer’s recommendations.
-
bioRxiv - Cancer Biology 2024Quote: ... 20 ng/ml human basic fibroblast growth factor (Stemcell Technologies, 78003), 2 μg/ml heparin (Stemcell Technologies ...
-
bioRxiv - Cancer Biology 2023Quote: ... which consisted of NS-A Basal Medium (Human) (STEMCELL Technologies, 05750) supplemented with 10% NeuroCult™ Proliferation Supplement (Human ...
-
bioRxiv - Bioengineering 2024Quote: ... or ReLeSRTM human PSC selection and passaging reagent (Stemcell Technologies; 05872). The differentiation of iPSCs into foregut cells was performed using previously published protocols13,21 ...
-
bioRxiv - Bioengineering 2024Quote: ... and 6 × 103 human bone marrow CD34+ cells (STEMCELL Technologies, 70002.3) into a collagen-based hydrogel according to the protocol described previously (49 ...
-
bioRxiv - Neuroscience 2024Quote: ... with 10% human platelet-derived lysate (Stem Cell Technologies, Cat#06960) and 1% Penicillin-Streptomycin solution (Pen-Strep ...
-
bioRxiv - Cancer Biology 2024Quote: The RosetteSep™ Human CD45 Depletion Cocktail (Catalog #15112, StemCell Technologies) was used in this study to enrich cancer cells spiked into whole blood ...
-
bioRxiv - Cancer Biology 2022Quote: ... all the unwanted cells were labelled with magnet conjugated antibody cocktail which is separated using their EasySep magnetic stand leaving CD4 or CD8 cell in suspension using the vendor supplied EasySep Human CD4/CD8 T Cell Iso Kit (Stem Cell Technologies, 17952 for CD4 and 17953 for CD8). This negative selection approach results in isolation of untouched CD8 or CD4 T cells and stored frozen with 10% DMSO (MP Biomedicals ...
-
bioRxiv - Cancer Biology 2022Quote: ... BT179 and BT333 were maintained in NeuroCult proliferation medium (human) (StemCell Technologies) with 20 ng/ml EGF ...
-
bioRxiv - Molecular Biology 2021Quote: ... were suspended in Intesticult (INT) human organoid growth medium (Stem Cell Technologies) proliferation medium ...
-
bioRxiv - Neuroscience 2019Quote: ... ImmunoCult Human CD3/CD28 T cell Activator and 20ng rhIL2 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Neuroscience 2019Quote: ... anti-human CD40 antibody (clone 5C3) and 20 ng rhIL4 (Stemcell Technologies) was added to culture medium ...
-
bioRxiv - Immunology 2021Quote: PBMCs were isolated from six human peripheral blood leukapheresis packs (STEMCELL Technologies) using Ficoll gradient density centrifugation ...
-
bioRxiv - Bioengineering 2021Quote: ... human iPSCs were cultured in mTeSR+ stem cell medium (Stem Cell Technologies) on Matrigel coated plates (Corning ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1), and 10 ng/mL GDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2021Quote: ... TNF alpha (0.5ng/mL final concentration in PBS, human recombinant, Stemcell Tech) was added to half of the wells ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 20 ng/ml human recombinant bFGF (Stem Cell Technologies cat# 78003). For 10 gBlocks pool ...